Nomura Holdings
ACAD icon

Nomura Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

Nomura Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759K Hold
30,000
– – ﹤0.01% 1430
2026
Q1 		$668K Buy
30,000
+11,900
+66% +$284K ﹤0.01% 1275
2025
Q4 		$483K Buy
+18,100
New +$433K ﹤0.01% 1535
2025
Q3 		– Sell
-24,100
Closed -$520K – 1840
2025
Q2 		$520K Buy
+24,100
New +$448K ﹤0.01% 1129

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nomura Holdings's ACAD Position: Q2 2026 in Review

Nomura Holdings opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 17,456 shares worth $442K. The stake represents ﹤0.01% of the portfolio and ranks #1538 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in ACAD as recently as Q3 2025.

Nomura Holdings first reported a position in ACAD in Q3 2013 and has held it in 8 quarters since. The position peaked at $14.8M in Q4 2022. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Nomura Holdings held 17,456 shares of Acadia Pharmaceuticals worth $442K as of Q2 2026.
  • Acadia Pharmaceuticals was a new Nomura Holdings position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1538 holding.
  • Nomura Holdings first reported a position in Acadia Pharmaceuticals in Q3 2013 and has held it in 8 quarters since.
  • Nomura Holdings's Acadia Pharmaceuticals position peaked at $14.8M in Q4 2022.
  • 353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.